Background: Evidence of anticancer properties of garlic for different cancer sites has been reported previously in in vitro and in vivo experimental studies but there is limited epidemiologic evidence on the association between garlic and lung cancer.

Methods: We examined the association between raw garlic consumption and lung cancer in a case–control study conducted between 2005 and 2007 in Taiyuan, China. Epidemiologic data was collected by face-to-face interviews from 399 incident lung cancer cases and 466 healthy controls. We used unconditional logistic regression models to estimate crude and adjusted ORs (aOR) and their 95% confidence intervals (CI). Adjusted models controlled for age, sex, average annual household income 10 years ago, smoking, and indoor air pollution.

Results: Compared with no intake, raw garlic intake was associated with lower risk of development of lung cancer with a dose–response pattern (aOR for <2 times/week = 0.56; 95% CI, 0.39–0.81 and aOR for ≥2 times/week = 0.50; 95% CI, 0.34–0.74; Ptrend = 0.0002). Exploratory analysis showed an additive interaction of raw garlic consumption with indoor air pollution and with any supplement use in association with lung cancer.

Conclusions: The results of the current study suggest that raw garlic consumption is associated with reduced risk of lung cancer in a Chinese population.

Impact: This study contributes to the limited research in human population on the association between garlic and lung cancer and advocates further investigation into the use of garlic in chemoprevention of lung cancer. Cancer Epidemiol Biomarkers Prev; 25(4); 624–33. ©2016 AACR.

Garlic (Allium sativum) was used among several ancient civilizations across the world including Egypt (references as early as 3000 B.C.), Greece, Rome, India, and China to treat various ailments including poisoning, respiratory and gastric ailments, abnormal growths, headache, insomnia, and depression (1–3). In traditional Chinese medicine, garlic is used to improve cardiovascular health and immunity as well as to treat cancer (2, 4). Garlic was used in daily Chinese diet since around 2000 B.C. or earlier where it was consumed especially with raw meat (2). Currently, garlic is used as a popular spice in China, which is the largest producer and exporter of garlic (5).

Garlic is rich in organo-sulfur compounds (OSC), which are responsible for most of its therapeutic properties including antibacterial, antiprotozoal, antifungal, hypolipidemic, antiatherosclerotic, and anticancer properties (6, 7). The major OSCs that contribute to the anticancer properties of garlic include allicin, allixin, diallyl sulfide, diallyl disulfide, diallyl trisulfide, S-allyl cysteine allylmercaptan, allylmethyldisulfide, allylmethyltrisulfide, and ajoene (8–10). Several mechanisms including inhibiting cancer initiation, suppressing cancer promotion, and preventing oxidative damage have been attributed to the anticancer properties of garlic (7–9, 11, 12). In vitro and in vivo experimental studies provided evidence for the anticancer properties of garlic against stomach, liver, colon, prostate, skin, bladder, breast, and lung cancer (7, 13–17). Case–control studies conducted in different populations reported an inverse association between garlic consumption (raw/cooked) and colorectal, prostate, and head and neck cancers (18–20). However, Dutch prospective cohort studies showed no inverse association between garlic supplement intake and gastric, colorectal, breast, and lung cancers (21–24). Thus, consistent epidemiologic evidence on the protective effects of garlic against different cancers is lacking.

In 2012, lung cancer accounted for 13% of total cancer cases and 19% of total cancer-related deaths worldwide (25). In China, lung cancer is the most common cancer in incidence and mortality (2011 statistics) with a higher age-standardized mortality of 28.0 per 100,000, compared with the world population (19.7/100,000; refs. 25, 26). In the past 30 years, lung cancer mortality in China increased by 464.84% (27). Smoking, exposure to secondhand smoke, and air pollution (both outdoor and from indoor household fuel combustion) are the major risk factors of lung cancer in China (27). Evidence from previous epidemiologic studies suggests that the factors that may be protective against lung cancer are mainly related to diet, especially higher consumption of fruits and vegetables (28–30).

The existing epidemiologic evidence of the association between garlic and lung cancer (Table 1) is limited and inconsistent (21, 31–35). Review of previous literature indicates that raw/cooked garlic rather than a more processed form (e.g., supplements) was inversely associated with the risk of cancer (36). In addition, heating garlic seems to drastically diminish its anticarcinogenic properties (37–40). Therefore, raw garlic may potentially possess better anticancer properties compared with heated/cooked/processed garlic. Compared with the Chinese, raw garlic intake among other populations is very low, which makes it difficult to analyze disease associations (36). For example, in 1995, the annual average consumption of fresh garlic per person in Cangshan County, Shangdong Province, China was 6 kg whereas it was only 0.8 kg in the United States (41). Thus, the Chinese population is probably better suited for studying the association between garlic intake and cancer.

Table 1.

Review of relationship between garlic consumption and lung cancer from published epidemiologic studies

ReferenceStudy designStudy populationStudy sampleGarlic (form)Garlic consumptionResultsComments
Jin et al. (2013)a Case–control study (population-based multicenter study) China (Jiangsu province) 1,424 cases/4,543 controls Raw garlic  Estimated OR 
  • Adjusted for age, gender, education, income, BMI, family history, smoking, alcohol drinking, and study area.

 
     Never 1.00  
     <2 times/week 0.92 (0.79–1.08)  
     ≥2 times/week 0.56 (0.44–0.72)  
      Ptrend = <0.001  
Lin et al. (2012)b Case–control study China -women (Fujian province) 226 cases/269 controls matched on age Raw garlic  Estimated OR 
  • Adjusted for age, cooking oil fumes, use of fume extractor and environmental tobacco smoke

 
     No consumption 1.00  
     1–2 times/week 0.79 (0.49–1.28)  
     >2 times/week 0.37 (0.16–0.84)  
Satia et al. (2009)c Prospective cohort study USA (Washington state 665 lung cancer cases/76,460 non-lung cancer individuals Garlic supplement pills (past 10 years use)  Estimated HR 
  • Adjusted for age, gender, education, years smoked, pack-years, and pack-years squared.

  • Study examined association of lung cancer risk with various herbal and specialty supplement use during the past 10 years

 
     Nonuser 1.00  
     User 1.09 (0.83–1.34)  
Linseisen et al. (2007)d Prospective cohort study 10 European countries 1,126 lung cancer cases/478,590 cohort members followed Garlic vegetable Quintiles of consumption Estimated hazard risk 
  • Adjusted for smoking status and duration, education, physical activity at work, intake of red meat, intake of processed meat, height, weight, nonfat energy intake, energy intake from fat, and ethanol intake at baseline.

  • Results from European Prospective Investigation into Cancer and Nutrition (EPIC) study—updated from Miller et al (2003) publication.

 
      No association found  
Le Marchand et al. (2000)e Case–control study (population based) Hawaii, USA 582 cases/582 controls matched on age, sex, and ethnicity Garlic vegetable Quartiles of consumption Estimated OR 
  • Adjusted for smoking status, duration of smoking, number of cigarettes smoked per day, intakes of β-carotene and saturated fat.

  • Form of garlic (raw/cooked/other) for consumption was not specified

 
     Quartile 1 1.00  
     Quartile 2 0.9 (0.6–1.4)  
     Quartile 3 0.8 (0.5–1.2)  
     Quartile 4 0.7 (0.4–1.1)  
      Ptrend = 0.12  
Dorant et al. (1994)f Case–cohort Netherlands 484 lung cancer cases/3,123 noncancer controls Garlic supplements  Estimated rate ratio 
  • Adjusted for age, gender, pack-years of current and past smoking, education, history of COPD, onion and leek consumption, vitamin C and β-carotene.

 
     No sup use 1.00  
     Garlic sup only 1.78 (1.08–2.92)  
     Other sup only 1.00  
     Garlic and other sup 0.93 (0.46–1.86)  
ReferenceStudy designStudy populationStudy sampleGarlic (form)Garlic consumptionResultsComments
Jin et al. (2013)a Case–control study (population-based multicenter study) China (Jiangsu province) 1,424 cases/4,543 controls Raw garlic  Estimated OR 
  • Adjusted for age, gender, education, income, BMI, family history, smoking, alcohol drinking, and study area.

 
     Never 1.00  
     <2 times/week 0.92 (0.79–1.08)  
     ≥2 times/week 0.56 (0.44–0.72)  
      Ptrend = <0.001  
Lin et al. (2012)b Case–control study China -women (Fujian province) 226 cases/269 controls matched on age Raw garlic  Estimated OR 
  • Adjusted for age, cooking oil fumes, use of fume extractor and environmental tobacco smoke

 
     No consumption 1.00  
     1–2 times/week 0.79 (0.49–1.28)  
     >2 times/week 0.37 (0.16–0.84)  
Satia et al. (2009)c Prospective cohort study USA (Washington state 665 lung cancer cases/76,460 non-lung cancer individuals Garlic supplement pills (past 10 years use)  Estimated HR 
  • Adjusted for age, gender, education, years smoked, pack-years, and pack-years squared.

  • Study examined association of lung cancer risk with various herbal and specialty supplement use during the past 10 years

 
     Nonuser 1.00  
     User 1.09 (0.83–1.34)  
Linseisen et al. (2007)d Prospective cohort study 10 European countries 1,126 lung cancer cases/478,590 cohort members followed Garlic vegetable Quintiles of consumption Estimated hazard risk 
  • Adjusted for smoking status and duration, education, physical activity at work, intake of red meat, intake of processed meat, height, weight, nonfat energy intake, energy intake from fat, and ethanol intake at baseline.

  • Results from European Prospective Investigation into Cancer and Nutrition (EPIC) study—updated from Miller et al (2003) publication.

 
      No association found  
Le Marchand et al. (2000)e Case–control study (population based) Hawaii, USA 582 cases/582 controls matched on age, sex, and ethnicity Garlic vegetable Quartiles of consumption Estimated OR 
  • Adjusted for smoking status, duration of smoking, number of cigarettes smoked per day, intakes of β-carotene and saturated fat.

  • Form of garlic (raw/cooked/other) for consumption was not specified

 
     Quartile 1 1.00  
     Quartile 2 0.9 (0.6–1.4)  
     Quartile 3 0.8 (0.5–1.2)  
     Quartile 4 0.7 (0.4–1.1)  
      Ptrend = 0.12  
Dorant et al. (1994)f Case–cohort Netherlands 484 lung cancer cases/3,123 noncancer controls Garlic supplements  Estimated rate ratio 
  • Adjusted for age, gender, pack-years of current and past smoking, education, history of COPD, onion and leek consumption, vitamin C and β-carotene.

 
     No sup use 1.00  
     Garlic sup only 1.78 (1.08–2.92)  
     Other sup only 1.00  
     Garlic and other sup 0.93 (0.46–1.86)  

NOTE: Statistically significant estimates are presented in bold font.

Abbreviation: sup, supplements.

aRef. 31.

bRef. 33.

cRef. 35.

dRef. 34.

eRef. 32.

fRef. 21.

Only two recent case–control studies in Chinese population investigated the association between raw garlic consumption and lung cancer. Both studies reported that higher consumption of raw garlic (two or more times per week) was protective against lung cancer (31, 33). In the current study, we analyzed data collected from a case–control study conducted in Taiyuan city, Shanxi Province, China and sought to replicate the association between raw garlic consumption and lung cancer. In addition, we explored for interaction between major risk factors and raw garlic consumption in association with lung cancer.

Study population

Cases were recruited between 2005 and 2007 from Shanxi Tumor Hospital, where about 70% of cancer patients from Taiyuan city sought treatment. Eligible cases were newly diagnosed lung cancer patients who were ages 20 years or older, lived in Taiyuan city for 10 years or more, in stable medical condition, and willing to participate in the study. Controls were randomly selected from resident lists of 13 communities covering most of Taiyuan city to match cases according to the distribution of age and gender. Eligibility criteria for controls were same as the cases but controls had no history of cancer or any other serious chronic disease. A total of 399 cases (89% response rate) and 466 controls (85% response rate) participated in the study. Informed consent was obtained from study participants before completing the study questionnaire. A detailed description regarding participant recruitment was previously published (42).

Data collection

Epidemiologic data was collected by trained study personnel using a structured questionnaire to conduct face-to-face interviews of all cases at the hospital and all controls at community health centers. The questionnaire included information on demographic characteristics, residence and housing history, living and cooking habits, smoking, alcohol drinking, tea drinking, and personal and family medical history. “Ever-smokers” were defined as those who smoked at least 100 cigarettes during their lifetime. Dietary intake 1 year ago was evaluated using 96-item food frequency questionnaire and other questions on specific items. Raw garlic intake was assessed by asking “How often do you eat raw garlic?” Participants chose one of the following responses: (i) never, (ii) occasionally (<2 times/week), (iii) often (≥2 times/week), (iv) do not know. We assessed overall exposure to indoor air pollution (IAP) 10 years prior to the date of interview by creating an IAP index, which was based on an individual's exposure to five major risk factors including solid fuel use for cooking and heating, ventilation in kitchen, opening of windows in winter, and secondhand smoking. Exposure to each risk factor was scored as “1” and based on the number of the above five risk factors that an individual was exposed to, an IAP index of 0–5 was assigned.

Statistical analysis

We used χ2 and t tests to test the differences in distribution of selected demographic characteristics (age, sex, education, average annual household income 10 years ago), body mass index (BMI), smoking, IAP exposure (IAP index of 0 = none, 1–2 = low, and 3–5 = high) alcohol drinking, tea drinking, and supplement use (intake of one or more of the following—vitamin A, β-carotene, vitamin C, vitamin E, calcium, selenium, zinc, or multivitamin) among cases and controls. We also tested differences in the distribution of the above characteristics by raw garlic consumption (never, <2 times/week, and ≥2 times/week) using χ2 and one-way ANOVA tests. For the analysis in the current study, we excluded 7 participants who did not report their intake of raw garlic. Unconditional logistic regression models were used to estimate crude and adjusted ORs (aOR) and 95% confidence intervals (CI) for the association between raw garlic intake and lung cancer. On the basis of prior knowledge and review of previous relevant literature, selected covariables including education, average annual household income 10 years ago, BMI, pack-years of smoking, IAP, alcohol drinking, tea drinking, and supplement use were tested for association with the exposure and/or the disease in the study population. Education, BMI, pack-years of smoking, IAP, and supplement use were associated with lung cancer but not with raw garlic intake. Average annual household income 10 years ago was the only variable that was associated with both raw garlic intake and lung cancer. Age and sex being frequency-matching variables, were included in the multivariate model. We generated two multivariate models to present the results of logistic regression. Model 1 adjusted for age, sex, and average annual household income. Model 2 additionally adjusted for smoking and IAP considering that they were among the strongest risk factors for lung cancer in the Chinese population. The results from a saturated multivariable model that included all covariables were similar to the results from Model 2. We chose to use Model 2 as the final multivariate model. The association between raw garlic consumption and lung cancer was estimated in the overall population as well as in subgroups of age, sex, smoking, IAP, alcohol drinking, tea drinking, supplement use, and by histologic subtypes of lung cancer. We also evaluated for multiplicative and additive interaction of raw garlic consumption with age (0 = <55 years, 1 = ≥55 years), smoking status (0 = never, 1 = ever), IAP (0 = no/low, 1 = high), alcohol drinking (0 = no, 1 = yes), tea drinking (0 = never, 1 = ever), and supplement use (0 = no, 1 = yes) in association with lung cancer. Raw garlic consumption was operationalized as 0 = “never” and 1 = “any” intake for interaction analysis. Multiplicative interaction was evaluated by including the main effect variables and their product term in logistic regression models. A ratio of ORs estimate of the product term was considered statistically significant if the CI did not include “1.00.” Additive interaction was assessed by calculating relative excess risk of interaction (RERI) and inclusion of “0.00” within the CIs of RERI estimate indicated absence of more than additivity or no additive interaction. All analyses were performed using SAS 9.4 software.

Approximately 56% of study participants were ages 55 years or older and approximately half of the participants were males. Differences in distribution of study characteristics between cases and controls are presented in Table 2. Cases had a higher mean age and a higher proportion of cases were exposed to high IAP. Education, average annual household income 10 years ago, BMI, and supplement use were higher among controls. Approximately 55% of cases (93% males and 17% females) were ever-smokers compared with 39% of controls (71% males and 6% females). The smoking prevalence among female cases is similar to that observed in previous studies in Chinese population (43–45).

Table 2.

Distribution of study characteristics among lung cancer cases and cancer-free controls

Cases (N = 399)Controls (N = 466)
VariablesN (%)N (%)Pa
Age (years) 
 ≤44 59 (14.8) 83 (17.8) 0.07 
 45–54 96 (24.1) 139 (29.8)  
 55–64 111 (27.8) 116 (24.9)  
 ≥65 133 (33.3) 128 (27.5)  
 Mean (SD) 58.1 (11.9) 56.1 (11.3) 0.01 
Sex 
 Male 202 (50.6) 234 (50.2) 0.90 
 Female 197 (49.4) 232 (49.8)  
Education 
 Illiteracy 43 (10.8) 23 (4.9) <0.0001 
 Primary school 106 (26.6) 81 (17.4)  
 Middle school 124 (31.1) 175 (37.5)  
 High school 68 (17.0) 120 (25.8)  
 College and above 58 (14.5) 67 (14.4)  
Average annual income/person 10 years ago (RMB)b 
 <1,000 104 (26.1) 106 (22.7) <0.0001 
 1,000–2,499 236 (59.1) 197 (42.3)  
 2,500–4,999 37 (9.3) 116 (24.9)  
 ≥5,000 22 (5.5) 47 (10.1)  
 Mean (SD) 1,994.5 (2,678.9) 2,539.4 (3,193.7) 0.007 
BMI (kg/m2
 <18.5 22 (5.8) 9 (2.0) <0.0001 
 18.5–24.9 250 (66.3) 259 (56.3)  
 25–29.9 90 (23.9) 162 (35.2)  
 ≥30 15 (4.0) 30 (6.5)  
 Mean (SD) 23.4 (3.6) 24.8 (3.9) <0.0001 
Pack-years of smoking 
 Never-smokersc 179 (44.9) 285 (61.2) <0.0001 
 <30 64 (16.0) 107 (22.9)  
 ≥30 156 (39.1) 74 (15.9)  
IAPd 
 None 38 (10.8) 90 (19.7) <0.0001 
 Low 145 (41.2) 253 (55.2)  
 High 169 (48.0) 115 (25.1)  
Alcohol drinkinge 
 Never 298 (74.7) 345 (74.0) 0.83 
 Ever 101 (25.3) 121 (26.0)  
Tea drinking 
 Never 242 (60.7) 263 (56.4) 0.21 
 Ever 157 (39.3) 203 (43.6)  
Supplement usef 
 No 342 (87.0) 355 (77.2) 0.0002 
 Yes 51 (13.0) 105 (22.8)  
Cases (N = 399)Controls (N = 466)
VariablesN (%)N (%)Pa
Age (years) 
 ≤44 59 (14.8) 83 (17.8) 0.07 
 45–54 96 (24.1) 139 (29.8)  
 55–64 111 (27.8) 116 (24.9)  
 ≥65 133 (33.3) 128 (27.5)  
 Mean (SD) 58.1 (11.9) 56.1 (11.3) 0.01 
Sex 
 Male 202 (50.6) 234 (50.2) 0.90 
 Female 197 (49.4) 232 (49.8)  
Education 
 Illiteracy 43 (10.8) 23 (4.9) <0.0001 
 Primary school 106 (26.6) 81 (17.4)  
 Middle school 124 (31.1) 175 (37.5)  
 High school 68 (17.0) 120 (25.8)  
 College and above 58 (14.5) 67 (14.4)  
Average annual income/person 10 years ago (RMB)b 
 <1,000 104 (26.1) 106 (22.7) <0.0001 
 1,000–2,499 236 (59.1) 197 (42.3)  
 2,500–4,999 37 (9.3) 116 (24.9)  
 ≥5,000 22 (5.5) 47 (10.1)  
 Mean (SD) 1,994.5 (2,678.9) 2,539.4 (3,193.7) 0.007 
BMI (kg/m2
 <18.5 22 (5.8) 9 (2.0) <0.0001 
 18.5–24.9 250 (66.3) 259 (56.3)  
 25–29.9 90 (23.9) 162 (35.2)  
 ≥30 15 (4.0) 30 (6.5)  
 Mean (SD) 23.4 (3.6) 24.8 (3.9) <0.0001 
Pack-years of smoking 
 Never-smokersc 179 (44.9) 285 (61.2) <0.0001 
 <30 64 (16.0) 107 (22.9)  
 ≥30 156 (39.1) 74 (15.9)  
IAPd 
 None 38 (10.8) 90 (19.7) <0.0001 
 Low 145 (41.2) 253 (55.2)  
 High 169 (48.0) 115 (25.1)  
Alcohol drinkinge 
 Never 298 (74.7) 345 (74.0) 0.83 
 Ever 101 (25.3) 121 (26.0)  
Tea drinking 
 Never 242 (60.7) 263 (56.4) 0.21 
 Ever 157 (39.3) 203 (43.6)  
Supplement usef 
 No 342 (87.0) 355 (77.2) 0.0002 
 Yes 51 (13.0) 105 (22.8)  

aFrom two-sided χ2 test for categorical variables and from t test for continuous variables. P values in bold represent statistical significance.

bRMB, Renminbi, the Chinese currency.

cSmoked less than 100 cigarettes during lifetime.

dIAP exposure was calculated by summarizing participant's exposure to solid fuel for cooking and heating, ventilation in kitchen, opening of windows in winter, and secondhand smoking (an index of 0 = none, 1–2 = low, and 3–5 = high IAP).

eLifetime alcohol drinking status.

fSupplement use includes intake of one or more of the following: vitamin A, β-carotene, vitamin C, vitamin E, calcium, selenium, zinc, or multivitamins.

Table 3 shows the distribution of study characteristics by participants' raw garlic consumption. We did not find differences in the distribution of any of the study characteristics except for average annual household income 10 years ago. High income participants (≥2,500 Renminbi) consumed higher amounts of raw garlic (≥2 times/week) compared with those with lower income. Smoking exposure did not differ by raw garlic consumption.

Table 3.

Distribution of study characteristics by categories of participants' consumption of raw garlic

Raw garlic consumption
Never (N = 357)<2 times/week (N = 244)≥2 times/week (N = 239)
VariableN (%)N (%)N (%)Pa
Age (years) 
 ≤44 53 (14.9) 50 (20.5) 39 (16.3) 0.46 
 45–54 100 (28.0) 65 (26.6) 69 (28.9)  
 55–64 101 (28.3) 64 (26.3) 55 (23.0)  
 ≥65 103 (28.8) 65 (26.6) 76 (31.8)  
 Mean (SD) 57.2 (11.2) 56.1 (11.7) 56.7 (12.1) 0.53 
Sex 
 Male 175 (49.0) 115 (47.1) 126 (52.7) 0.46 
 Female 182 (51.0) 129 (52.9) 113 (47.3)  
Education 
 Illiteracy 23 (6.4) 16 (6.6) 24 (10.0) 0.48 
 Primary school 88 (24.7) 45 (18.4) 48 (20.1)  
 Middle School 122 (34.2) 94 (38.6) 78 (32.6)  
 High School 74 (20.7) 55 (22.5) 53 (22.2)  
 College and above 50 (14.0) 34 (13.9) 36 (15.1)  
Average annual household income 10 years ago (RMB)b 
 <1,000 106 (29.7) 53 (21.7) 48 (20.1) 0.0006 
 1,000–2,499 181 (50.7) 133 (54.5) 106 (44.3)  
 2,500–4,999 47 (13.2) 39 (16.0) 58 (24.3)  
 ≥5,000 23 (6.4) 19 (7.8) 27 (11.3)  
 Mean (SD) 2,033.7 (2,590.5) 2,289.5 (3,237.3) 2,685.0 (3,330.4) 0.04 
BMI (kg/m2
 <18.5 17 (4.9) 6 (2.6) 8 (3.5) 0.82 
 18.5–24.9 215 (61.4) 147 (62.8) 137 (59.6)  
 25–29.9 99 (28.3) 70 (29.9) 73 (31.7)  
 ≥30 19 (5.4) 11 (4.7) 12 (5.2)  
 Mean (SD) 23.9 (4.1) 24.2 (3.6) 24.3 (3.7) 0.53 
Pack-years of smoking 
 Never-smokersc 195 (54.6) 135 (55.3) 124 (51.8) 0.89 
 <30 67 (18.8) 46 (18.9) 52 (21.8)  
 ≥30 95 (26.6) 63 (25.8) 63 (26.4)  
IAPd 
 None 46 (13.6) 31 (13.6) 46 (20.9) 0.11 
 Low 162 (47.9) 119 (52.2) 100 (45.5)  
 High 130 (38.5) 78 (34.2) 74 (33.6)  
Alcohol drinkinge 
 Never 274 (76.8) 188 (77.0) 168 (70.3) 0.14 
 Ever 83 (23.2) 56 (23.0) 71 (29.7)  
Tea drinking 
 Never 212 (59.4) 146 (59.8) 134 (56.1) 0.65 
 Ever 145 (40.6) 98 (40.2) 105 (43.9)  
Supplement usef 
 No 294 (83.8) 191 (78.9) 197 (83.5) 0.27 
 Yes 57 (16.2) 51 (21.1) 39 (16.5)  
Raw garlic consumption
Never (N = 357)<2 times/week (N = 244)≥2 times/week (N = 239)
VariableN (%)N (%)N (%)Pa
Age (years) 
 ≤44 53 (14.9) 50 (20.5) 39 (16.3) 0.46 
 45–54 100 (28.0) 65 (26.6) 69 (28.9)  
 55–64 101 (28.3) 64 (26.3) 55 (23.0)  
 ≥65 103 (28.8) 65 (26.6) 76 (31.8)  
 Mean (SD) 57.2 (11.2) 56.1 (11.7) 56.7 (12.1) 0.53 
Sex 
 Male 175 (49.0) 115 (47.1) 126 (52.7) 0.46 
 Female 182 (51.0) 129 (52.9) 113 (47.3)  
Education 
 Illiteracy 23 (6.4) 16 (6.6) 24 (10.0) 0.48 
 Primary school 88 (24.7) 45 (18.4) 48 (20.1)  
 Middle School 122 (34.2) 94 (38.6) 78 (32.6)  
 High School 74 (20.7) 55 (22.5) 53 (22.2)  
 College and above 50 (14.0) 34 (13.9) 36 (15.1)  
Average annual household income 10 years ago (RMB)b 
 <1,000 106 (29.7) 53 (21.7) 48 (20.1) 0.0006 
 1,000–2,499 181 (50.7) 133 (54.5) 106 (44.3)  
 2,500–4,999 47 (13.2) 39 (16.0) 58 (24.3)  
 ≥5,000 23 (6.4) 19 (7.8) 27 (11.3)  
 Mean (SD) 2,033.7 (2,590.5) 2,289.5 (3,237.3) 2,685.0 (3,330.4) 0.04 
BMI (kg/m2
 <18.5 17 (4.9) 6 (2.6) 8 (3.5) 0.82 
 18.5–24.9 215 (61.4) 147 (62.8) 137 (59.6)  
 25–29.9 99 (28.3) 70 (29.9) 73 (31.7)  
 ≥30 19 (5.4) 11 (4.7) 12 (5.2)  
 Mean (SD) 23.9 (4.1) 24.2 (3.6) 24.3 (3.7) 0.53 
Pack-years of smoking 
 Never-smokersc 195 (54.6) 135 (55.3) 124 (51.8) 0.89 
 <30 67 (18.8) 46 (18.9) 52 (21.8)  
 ≥30 95 (26.6) 63 (25.8) 63 (26.4)  
IAPd 
 None 46 (13.6) 31 (13.6) 46 (20.9) 0.11 
 Low 162 (47.9) 119 (52.2) 100 (45.5)  
 High 130 (38.5) 78 (34.2) 74 (33.6)  
Alcohol drinkinge 
 Never 274 (76.8) 188 (77.0) 168 (70.3) 0.14 
 Ever 83 (23.2) 56 (23.0) 71 (29.7)  
Tea drinking 
 Never 212 (59.4) 146 (59.8) 134 (56.1) 0.65 
 Ever 145 (40.6) 98 (40.2) 105 (43.9)  
Supplement usef 
 No 294 (83.8) 191 (78.9) 197 (83.5) 0.27 
 Yes 57 (16.2) 51 (21.1) 39 (16.5)  

aFrom two-sided χ2 test for categorical variables and from ANOVA for continuous variables. P values in bold represent statistical significance.

bRMB = Renminbi, the Chinese currency.

cSmoked less than 100 cigarettes during lifetime.

dIAP exposure was calculated by summarizing participant's exposure to solid fuel for cooking and heating, ventilation in kitchen, opening of windows in winter, and secondhand smoking (an index of 0 = none, 1–2 = low, and 3–5 = high IAP).

eLifetime alcohol drinking status.

fSupplement use includes intake of one or more of the following: vitamin A, β-carotene, vitamin C, vitamin E, calcium, selenium, zinc, or multivitamins.

The overall association of raw garlic consumption with lung cancer in crude and adjusted models is presented in Table 4. Raw garlic consumption in all categories (any intake, <2 times/week, ≥2 times/week) was inversely associated with lung cancer in the crude and both the multivariable models after adjusting for potential confounders. Compared with no intake, raw garlic consumption was inversely associated with lung cancer (<2 times/week, aOR = 0.56, 95% CI, 0.39–0.81; ≥2 times/week, aOR = 0.50, 95% CI, 0.34–0.74) with a dose–response relationship (Ptrend = 0.0002). We did not find notable differences between the results from the two multivariate models.

Table 4.

Association of raw garlic consumption with lung cancer

Cases (N = 392)Controls (N = 448)Model 1aModel 2b
aOR (95% CI)aOR (95% CI)
Raw garlic consumptionN (%)N (%)cOR (95% CI)
Never 197 (50.3) 160 (35.7) 1.00 1.00 1.00 
Any 195 (49.7) 288 (64.3) 0.55 (0.42–0.73) 0.59 (0.44–0.78) 0.52 (0.38–0.72) 
<2 times/week 104 (26.5) 140 (31.3) 0.60 (0.43–0.84) 0.61 (0.44–0.86) 0.56 (0.39–0.81) 
≥2 times/week 91 (23.2) 148 (33.0) 0.50 (0.36–0.70) 0.56 (0.40–0.80) 0.50 (0.34–0.74) 
Ptrend   <0.0001 0.0006 0.0002 
Cases (N = 392)Controls (N = 448)Model 1aModel 2b
aOR (95% CI)aOR (95% CI)
Raw garlic consumptionN (%)N (%)cOR (95% CI)
Never 197 (50.3) 160 (35.7) 1.00 1.00 1.00 
Any 195 (49.7) 288 (64.3) 0.55 (0.42–0.73) 0.59 (0.44–0.78) 0.52 (0.38–0.72) 
<2 times/week 104 (26.5) 140 (31.3) 0.60 (0.43–0.84) 0.61 (0.44–0.86) 0.56 (0.39–0.81) 
≥2 times/week 91 (23.2) 148 (33.0) 0.50 (0.36–0.70) 0.56 (0.40–0.80) 0.50 (0.34–0.74) 
Ptrend   <0.0001 0.0006 0.0002 

NOTE: Statistically significant OR and P values are presented in bold font.

Abbreviations: cOR, crude odds ratio; aOR, adjusted odds ratio.

aAdjusted for age (years), sex, and average household income 10 years ago (<1,000 = 1, 1,000—2,499 = 2, 2,500—4,999 = 3, ≥5,000 = 4).

bAdjusted for pack-years of smoking (continuous) and IAP (an index of 0 = none, 1–2 = low, and 3–5 = high IAP) in addition to the covariates in Model 1.

Table 5 shows the association between raw garlic consumption and lung cancer among any garlic consumers as well as those who consumed <2 times per week and ≥2 times per week, stratified by age, sex, smoking status, IAP, alcohol drinking, tea drinking, supplement use, and association with specific histopathologic subtypes of lung cancer. The association between raw garlic consumption and lung cancer was stronger in the younger age group, among females, and those exposed to IAP, whereas the association did not differ by smoking status, alcohol drinking, and tea drinking. The association with adenocarcinoma and squamous cell carcinoma subtypes was statistically significant. When these analyses were further stratified by sex, the associations seemed to be more prominent among women (Supplementary Table S1). However, these observations may not be sufficient to draw explicit conclusions because of the small sample sizes within the strata.

Table 5.

Association between raw garlic consumption and lung cancer stratified by major risk factors

NeverAny<2 times/week≥2 times/week
VariableCa/CoCa/CoaORa (95% CI)Ca/CoaORa (95% CI)Ca/CoaORa (95% CI)Ptrenda
Age (years) 
 <55 88/65 67/156 0.36 (0.23–0.58) 34/81 0.33 (0.19–0.58) 33/75 0.40 (0.23–0.72) <0.001 
 ≥55 109/95 128/132 0.69 (0.45–1.08) 70/59 0.82 (0.49–1.39) 58/73 0.57 (0.33–0.99) 0.049 
Sex 
 Males 92/83 103/138 0.64 (0.40–1.03) 54/61 0.68 (0.39–1.20) 49/77 0.60 (0.34–1.08) 0.071 
 Females 105/77 92/150 0.46 (0.30–0.72) 50/79 0.49 (0.29–0.81) 42/71 0.43 (0.25–0.75) 0.001 
Smoking status 
 Never 96/99 82/177 0.49 (0.32–0.76) 49/86 0.59 (0.35–0.97) 33/91 0.41 (0.24–0.71) <0.001 
 Ever 101/61 113/11 0.56 (0.34–0.91) 55/54 0.44 (0.20–0.96) 58/57 0.63 (0.28–1.41) 0.063 
Indoor air pollution 
 None 18/28 20/57 0.53 (0.21–1.36) 11/20 0.73 (0.24–2.23) 9/37 0.35 (0.11–1.10) 0.075 
 Low 74/88 66/153 0.52 (0.33–0.83) 39/80 0.58 (0.34–0.99) 27/73 0.45 (0.25–0.82) 0.006 
 High 88/42 80/72 0.49 (0.29–0.84) 40/38 0.44 (0.24–0.83) 40/34 0.62 (0.32–1.19) 0.077 
Alcohol drinking 
 No 148/126 146/210 0.57 (0.40–0.82) 83/105 0.65 (0.42–0.99) 63/105 0.51 (0.32–0.81) 0.003 
 Yes 49/34 49/78 0.41 (0.21–0.82) 21/35 0.34 (0.15–0.81) 28/43 0.53 (0.23–1.21) 0.078 
Tea drinking 
 Never 121/91 117/163 0.55 (0.36–82) 65/81 0.63 (0.39–1.00) 52/82 0.46 (0.29–0.77) 0.002 
 Ever 76/69 39/59 0.46 (0.27–0.78) 39/59 0.42 (0.22–0.80) 39/66 0.50 (0.26–0.95) 0.019 
Supplement useb 
 No 171/123 167/221 0.49 (0.34–0.69) 86/105 0.51 (0.33–0.77) 81/116 0.46 (0.30–0.72) <0.001 
 Yes 23/34 26/64 0.78 (0.33–1.87) 17/34 0.87 (0.32–2.31) 9/30 0.76 (0.24–2.35) 0.622 
Histopathology 
 ACC 53/160 54/288 0.55 (0.34–0.89) 33/140 0.67 (0.38–1.16) 21/148 0.43 (0.22–0.81) <0.001 
 SqCC 47/160 42/288 0.44 (0.25–0.77) 17/140 0.32 (0.15–0.67) 25/148 0.59 (0.30–1.17) 0.050 
 SmCC 26/160 31/288 0.61 (0.33–1.13) 17/140 0.60 (0.29–1.24) 14/148 0.58 (0.26–1.28) 0.136 
NeverAny<2 times/week≥2 times/week
VariableCa/CoCa/CoaORa (95% CI)Ca/CoaORa (95% CI)Ca/CoaORa (95% CI)Ptrenda
Age (years) 
 <55 88/65 67/156 0.36 (0.23–0.58) 34/81 0.33 (0.19–0.58) 33/75 0.40 (0.23–0.72) <0.001 
 ≥55 109/95 128/132 0.69 (0.45–1.08) 70/59 0.82 (0.49–1.39) 58/73 0.57 (0.33–0.99) 0.049 
Sex 
 Males 92/83 103/138 0.64 (0.40–1.03) 54/61 0.68 (0.39–1.20) 49/77 0.60 (0.34–1.08) 0.071 
 Females 105/77 92/150 0.46 (0.30–0.72) 50/79 0.49 (0.29–0.81) 42/71 0.43 (0.25–0.75) 0.001 
Smoking status 
 Never 96/99 82/177 0.49 (0.32–0.76) 49/86 0.59 (0.35–0.97) 33/91 0.41 (0.24–0.71) <0.001 
 Ever 101/61 113/11 0.56 (0.34–0.91) 55/54 0.44 (0.20–0.96) 58/57 0.63 (0.28–1.41) 0.063 
Indoor air pollution 
 None 18/28 20/57 0.53 (0.21–1.36) 11/20 0.73 (0.24–2.23) 9/37 0.35 (0.11–1.10) 0.075 
 Low 74/88 66/153 0.52 (0.33–0.83) 39/80 0.58 (0.34–0.99) 27/73 0.45 (0.25–0.82) 0.006 
 High 88/42 80/72 0.49 (0.29–0.84) 40/38 0.44 (0.24–0.83) 40/34 0.62 (0.32–1.19) 0.077 
Alcohol drinking 
 No 148/126 146/210 0.57 (0.40–0.82) 83/105 0.65 (0.42–0.99) 63/105 0.51 (0.32–0.81) 0.003 
 Yes 49/34 49/78 0.41 (0.21–0.82) 21/35 0.34 (0.15–0.81) 28/43 0.53 (0.23–1.21) 0.078 
Tea drinking 
 Never 121/91 117/163 0.55 (0.36–82) 65/81 0.63 (0.39–1.00) 52/82 0.46 (0.29–0.77) 0.002 
 Ever 76/69 39/59 0.46 (0.27–0.78) 39/59 0.42 (0.22–0.80) 39/66 0.50 (0.26–0.95) 0.019 
Supplement useb 
 No 171/123 167/221 0.49 (0.34–0.69) 86/105 0.51 (0.33–0.77) 81/116 0.46 (0.30–0.72) <0.001 
 Yes 23/34 26/64 0.78 (0.33–1.87) 17/34 0.87 (0.32–2.31) 9/30 0.76 (0.24–2.35) 0.622 
Histopathology 
 ACC 53/160 54/288 0.55 (0.34–0.89) 33/140 0.67 (0.38–1.16) 21/148 0.43 (0.22–0.81) <0.001 
 SqCC 47/160 42/288 0.44 (0.25–0.77) 17/140 0.32 (0.15–0.67) 25/148 0.59 (0.30–1.17) 0.050 
 SmCC 26/160 31/288 0.61 (0.33–1.13) 17/140 0.60 (0.29–1.24) 14/148 0.58 (0.26–1.28) 0.136 

Abbreviations: Ca/Co, cases/controls; aOR, adjusted odds ratio; ACC, adenocarcinoma, SqCC, squamous cell carcinoma; SmCC, small cell carcinoma.

aAdjusted for age (in years except for subgroups of age), sex (except for subgroups of sex), average annual household income 10 years ago (<1,000 = 1, 1,000–2,499 = 2, 2,500–4,999 = 3, ≥5,000 = 4), pack-years of smoking (continuous, except for subgroups of smoking), and IAP (an index of 0 = none, 1–2 = low, and 3–5 = high IAP except for subgroups of IAP).

bSupplement use includes intake of one or more of the following: vitamin A, β-carotene, vitamin C, vitamin E, calcium, selenium, zinc, or multivitamins. Statistically significant OR estimates and P values are presented in bold font.

Figure 1 depicts the results of the exploratory interaction analyses between raw garlic consumption and selected risk factors in association with lung cancer. We observed additive interaction between IAP and raw garlic consumption (aRERI = 0.37, 95% CI, 0.05–0.68) as well as supplement use and raw garlic consumption (aRERI = 0.41, 95% CI, 0.08–0.74) in association with lung cancer.

Figure 1.

Charts depicting the joint effects of raw garlic consumption and selected risk factors in association with lung cancer. G+, any raw garlic intake; G−, no raw garlic intake; A+, age ≥55 years; A−, age <55 years; S+, ever-smokers; S−, never-smokers; IP+, high IAP; IP−, low/no IAP; Al+, alcohol ever-drinkers; Al−, alcohol never-drinkers; T+, tea ever-drinkers; T−, tea never-drinkers; Sp+, supplement users; Sp−, supplement nonusers. a, adjusted for age (in years, except for interaction with age), sex, average household income 10 years ago (<1,000 = 1, 1,000–2,499 = 2, 2,500–4,999 = 3, ≥5,000 = 4), pack-years of smoking (continuous, except for interaction with smoking), and IAP (an index of 0 = none, 1–2 = low, and 3–5 = high IAP, except for interaction with IAP); b, supplemental use includes intake of one or more of the following: vitamin A, β-carotene, vitamin C, vitamin E, calcium, selenium, zinc, or multivitamins. Additive interaction between IAP and raw garlic consumption (RERI = 0.37; 95% CI, 0.05–0.68) as well as supplement use and raw garlic consumption (RERI = 0.41; 95% CI, 0.08–0.74).

Figure 1.

Charts depicting the joint effects of raw garlic consumption and selected risk factors in association with lung cancer. G+, any raw garlic intake; G−, no raw garlic intake; A+, age ≥55 years; A−, age <55 years; S+, ever-smokers; S−, never-smokers; IP+, high IAP; IP−, low/no IAP; Al+, alcohol ever-drinkers; Al−, alcohol never-drinkers; T+, tea ever-drinkers; T−, tea never-drinkers; Sp+, supplement users; Sp−, supplement nonusers. a, adjusted for age (in years, except for interaction with age), sex, average household income 10 years ago (<1,000 = 1, 1,000–2,499 = 2, 2,500–4,999 = 3, ≥5,000 = 4), pack-years of smoking (continuous, except for interaction with smoking), and IAP (an index of 0 = none, 1–2 = low, and 3–5 = high IAP, except for interaction with IAP); b, supplemental use includes intake of one or more of the following: vitamin A, β-carotene, vitamin C, vitamin E, calcium, selenium, zinc, or multivitamins. Additive interaction between IAP and raw garlic consumption (RERI = 0.37; 95% CI, 0.05–0.68) as well as supplement use and raw garlic consumption (RERI = 0.41; 95% CI, 0.08–0.74).

Close modal

In the current study, we observed that raw garlic consumption was inversely associated with lung cancer with a dose–response relationship. The association between raw garlic consumption and lung cancer did not differ by smoking status, alcohol drinking, and tea drinking. We observed additive interaction between raw garlic consumption and IAP as well as between raw garlic consumption and supplement use in association with lung cancer.

Only two recent publications examined the association between raw garlic consumption and lung cancer and observed statistically significant inverse associations (31, 33). A case–control study conducted in Fujian Province, China reported that compared with no intake, consuming raw garlic more than two times per week was inversely associated with lung cancer (aOR = 0.37, 95% CI, 0.16–0.84). This association was slightly stronger than what we observed in the current study. The smaller sample size (226 cases and 269 controls), consisting of primarily nonsmoking women and the assessment of raw garlic consumption (no consumption, 1–2 times/week, >2 times/week) that is somewhat different from the current study could have contributed to the differences. The Fujian study did not report an association in the lower raw garlic consumption category (1–2 times/week).

Another case–control study with larger sample size (1424 cases and 4543 controls) conducted in Jiangsu Province, China reported an inverse association between raw garlic intake and lung cancer among those who consumed raw garlic ≥2 times per week (aOR = 0.56; 95% CI, 0.44–0.72; ref. 31). This association was similar to what we found in the current study. Similar to the Fujian study, the Jiangsu study did not find an association in the low garlic consumption category (<2 times/week). This may reflect the differences in the consumption of raw garlic in different geographic regions in China. The percentage of ever-garlic consumption was lower in the Jiangsu study (47.6%) compared with the current study (55.83%) and the use of garlic as an ingredient in the spices was not common among the residents of that province (31). Although there are some differences, the current study reiterated the findings of the previous two studies that raw garlic consumption of two or more times per week may be protective against lung cancer.

In the current study, we observed a slightly stronger association between raw garlic consumption and lung cancer among women and the younger participants (<55 years). Differences in smoking characteristics may have played a role in this observation. A dose–response relationship between raw garlic consumption and lung cancer was observed in never-smokers, but not in ever-smokers. Approximately 90% of women were never-smokers and the majority of participants in the younger age group were women and never-smokers. Although it may seem that the protective association between raw garlic consumption may be restricted to certain subgroups like women and never-smokers, the observations from the stratified analysis may not be sufficient to derive definite conclusions because of the limited sample size in the individual strata.

We observed that the association between raw garlic consumption and lung cancer was modified by IAP and supplement use on an additive scale. IAP is a major risk factor for lung cancer in China, with the major sources being fuel used for cooking and indoor heating (27, 42). Our finding indicates that the reduced risk of lung cancer associated with low/no exposure to IAP and consumption of raw garlic might be greater than the risk reduction associated with any one of the factors alone. We also observed an additive interaction between supplement use and raw garlic consumption in association with lung cancer. A recent review of clinical trials that investigated drugs for preventing lung cancer suggested that intake of vitamin and mineral supplements either alone or in combination do not reduce either incidence or mortality due to lung cancer (46). Other studies did not report consistent evidence for associations between lung cancer and the supplements taken by the majority of the participants in the current study (vitamin C, vitamin E, and calcium) who reported any supplement use (47–50). We do not have additional information to attribute the observed additive interaction between supplement use and raw garlic intake to any single supplement. Further targeted investigation with larger study samples is necessary to confirm potential interactions of garlic with other risk or protective factors in association with lung cancer.

Although the anticancer properties are mainly attributed to the bioactive OSCs, garlic contains other nutrients including flavonoids, oligosaccharides, arginine and potassium, vitamin C, and selenium that may contribute to its overall beneficial effects (51, 52). The major mechanisms contributing to the anticancer potential of garlic are: (i) inhibition of cancer initiation by suppressing the formation, intercepting metabolic activation, and enhancing enzyme detoxification of carcinogens (e.g., nitrosamines) as well as by inhibiting the formation of DNA adducts; (ii) blocking cancer promotion through antiproliferating activities including regulation of cell-cycle arrest in G2–M phase and promoting apoptosis in cancer cells; (iii) antioxidant activity formation and/or scavenging of free radicals. Other mechanisms include the inhibition of cancer cell growth by modification of histone acetylation, inhibition of angiogenesis, immunomodulation, and anti-inflammatory activity (8–12, 51, 53–56). The results of the current study align well with the anticancer mechanisms of garlic as described. When garlic is ingested, the active volatile compounds that are released in the stomach diffuse into the lung tissues (4) where the OSCs may act through the mechanisms described above to protect against lung cancer. Epidemiologic evidence based on results of meta-analyses show that higher consumption of fruits and vegetables may also protect against lung cancer (16, 30, 57). The association between raw garlic consumption and lung cancer seems to be stronger than the association with consumption of fruits (pooled OR = 0.80; 95% CI, 0.74–0.88) and consumption of vegetables (pooled OR = 0.74; 95% CI, 0.67–0.82; ref. 57). The numerous anticancer properties of garlic including high antiproliferative and antioxidant properties (58), which are mediated through multiple mechanisms, may explain the potential stronger protection effect of garlic alone against lung cancer. Further studies are needed to substantiate the evidence observed in the current study.

The current study has the following limitations: (i) sample size: our study results are based on a relatively small sample size but they do reiterate the findings from previous published studies regarding the relationship between raw garlic consumption and lung cancer. Our exploration for interaction with known risk factors for lung cancer may have been affected by the small sample sizes in subgroup analyses. Hence, we suggest interpreting the interaction results from the current study with caution. Raw garlic consumption may differ considerably by geographic region. Jin and colleagues reported that garlic consumption patterns differed even between the two counties in the Jiangsu province where the study was conducted, which may have influenced the magnitude of adjusted association compared with the crude model, more than smoking and other factors (31). Thus, more studies involving different populations and larger study samples are justified to verify the association between raw garlic consumption and lung cancer. (ii) Bias: as in any case–control study, the results of the current study may have been affected by bias. Incident lung cancer cases were recruited from Shanxi Tumor Hospital, visited by 70% of the cancer patients from Taiyuan city for treatment, whereas controls were selected from 13 communities of the same source population. The response rates for both cases and controls were high (89% for cases and 86% for controls). These design measures may have contributed to minimize selection bias. There are two possibilities for information bias. First, study personnel conducted face-to-face interviews with lung cancer patients in the hospital and controls were interviewed in community centers. The use of structured questionnaires and trained interviewers would have minimized any potential bias. Second, differential recall of raw garlic intake by cases and controls could have resulted in biased estimates. However, in both instances, as raw garlic intake was not thought to be associated with lung cancer at the time of data collection (31), any potential information bias would be nondifferential. This may have attenuated the estimate toward the null, which would make the current observed estimates conservative. (iii) Cooked garlic intake: we did not assess consumption of cooked garlic. Heating garlic seems to drastically diminish its anticarcinogenic properties (8, 38, 40). If we assume that a certain amount of anticancer potential is preserved in cooked garlic and participants in the “never raw garlic” group actually ate cooked garlic, it may lead to exposure misclassification. If the misclassification was nondifferential, the association between raw and cooked garlic and lung cancer would probably bias toward the null. Alternatively, higher proportion of cases than controls being misclassified would probably weaken the association whereas a higher proportion of controls than cases being misclassified would probably make the association stronger than the current observations. Considering the limited anticancer potential, we do not expect the association of raw and cooked garlic with lung cancer to significantly deviate from the current observed results. (iv) Raw garlic intake quantity: quantity of raw garlic intake was not assessed in the current study. A previous study in a Chinese population (Jiangsu Province) reported a similar pattern of association between raw garlic intake quantity and lung cancer when compared with the association using raw garlic consumption frequency (results were not presented; ref. 31). Although, we cannot make distinct conclusions based on the current study without the required data, we do not expect this to significantly impact our study results.

Despite the abovementioned limitations, the current study provides epidemiologic evidence to substantiate the protective effect of raw garlic against lung cancer, which has been indicated in previous in vitro studies that investigated the effects of garlic OSCs on human lung cancer cell lines (e.g., Calu-1, A-549 cells; refs. 14–17, 59, 60) as well as in animal models (61–63). Garlic OSCs were successfully tested for chemotherapy of cancers of various organs including breast (13), prostate, (64) and colon (65). Currently, many OSCs are being tested for their potential role in lung cancer treatment (14). A randomized phase IIb trial conducted in former and current smokers with a history of at least 30 pack-years showed that participants who received the OSC anethole dithiolethione as treatment had a higher reduction in progression of bronchial dysplasia and/or appearance of new lesions compared with those who received a placebo (66). Hence, garlic and garlic-derived OSCs show promise for lung cancer chemoprevention and chemotherapy. Further intervention trials and prospective studies are needed to verify the feasibility of using garlic or garlic OSCs in lung cancer prevention. In this regard, it is important to develop stable OSCs that can be successfully used in chemotherapy. Consuming raw garlic itself might provide a cost-effective method to prevent lung cancer. It would certainly seem more beneficial to promote intake of garlic as part of a healthy daily diet among never-smokers compared with ever-smokers. However, the magnitudes of association in the current and previous study (31) indicate that raw garlic consumption may be protective against lung cancer among never-smokers as well as ever-smokers.

Among Chinese men, the prevalence of cigarette smoking is extremely high (52.9%; ref. 67) and the percentage of ever-smokers who have quit (12.6%; ref. 67) is among the lowest in the world (67, 68). Encouraging smoking cessation through programs and policies reduces disease risk and helps to protect nonsmokers from the deleterious effects of secondhand smoke (69–71) and should be the first priority. It would also be prudent to promote consumption of raw garlic as a preventive approach against lung cancer, among both ever-smokers and never-smokers.

In conclusion, our results indicate that raw garlic consumption may protect against lung cancer in a Chinese population. As evidence from epidemiologic studies can be utilized to promote dietary modification in lung cancer prevention, further studies are warranted to confirm the observed association among different populations and with larger study sample sizes to establish the role and utility of garlic in lung cancer chemoprevention.

No potential conflicts of interest were disclosed.

Conception and design: Z.-F. Zhang, L. Mu

Development of methodology: S. Yu, Z.-F. Zhang, L. Mu

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): R. Niu, L. Liu, J. Li, J. Su, Z.-F. Zhang, L. Mu

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): A.A. Myneni, S.-C. Chang, M.K. Swanson, Z.-F. Zhang

Writing, review, and/or revision of the manuscript: A.A. Myneni, S.-C. Chang, M.K. Swanson, G.A. Giovino, Z.-F. Zhang, L. Mu

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): M.K. Swanson

Study supervision: S. Yu, L. Mu

The authors thank X. Han, B. Zhao, and J. Shi, who were part of the original data collection but were unable to be reached to contribute to this manuscript.

This work was supported in part by the National Nature Science Foundation of China grant award (to L. Mu; NSFC-30500417). The work is also partially supported by NIH grants (ES06718, CA09142, DA11386) awarded to Z.-F.Zhang and the Alper Research Center for Environmental Genomics of the UCLA Jonsson Comprehensive Cancer Center.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
Milner
JA
. 
A historical perspective on garlic and cancer
.
J Nutr
2001
;
131
:
1027S
31S
.
2.
Rivlin
RS
. 
Historical perspective on the use of garlic
.
J Nutr
2001
;
131
:
951S
4S
.
3.
Hahn
G
. In:
Koch
HP
,
Lawson
LD
,
editors
. 
Garlic: The science and therapeutic application of Allium Sativum L and related species
. 2nd ed.
Baltimore, MD
:
Williams & Wilkins
; 
1996
.
4.
Spezzatino.com [Internet]. Garlic: Garlic in Traditional Chinese Medicine; c2007-2010 [cited 2015 Nov 12]; p. 26–9. Available from
: http://spezzatino.com/issues/spezzatino-vol-9-garlic.pdf.
5.
Food and Agriculture Organization of the United Nations Statistics Division [Internet]. Rome, Italy. 2015
.
Crops: Average production of top 5 producers of garlic, 1993-2013; [cited 2015 Nov 12]; [about 1 screen]. Available from
: http://faostat3.fao.org/browse/Q/QC/E.
6.
Harris
JC
,
Cottrell
SL
,
Plummer
S
,
Lloyd
D
. 
Antimicrobial properties of Allium sativum (garlic)
.
Appl Microbiol Biotechnol
2001
;
57
:
282
6
.
7.
Khanum
F
,
Anilakumar
KR
,
Viswanathan
KR
. 
Anticarcinogenic properties of garlic: a review
.
Crit Rev Food Sci Nutr
2004
;
44
:
479
88
.
8.
Milner
JA
. 
Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis
.
Adv Exp Med Biol
2001
;
492
:
69
81
.
9.
Shukla
Y
,
Kalra
N
. 
Cancer chemoprevention with garlic and its constituents
.
Cancer Lett
2007
;
247
:
167
81
.
10.
Dorant
E
,
van den Brandt
PA
,
Goldbohm
RA
,
Hermus
RJ
,
Sturmans
F
. 
Garlic and its significance for the prevention of cancer in humans: a critical view
.
Br J Cancer
1993
;
67
:
424
9
.
11.
Cerella
C
,
Dicato
M
,
Jacob
C
,
Diederich
M
. 
Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds
.
Anticancer Agents Med Chem
2011
;
11
:
267
71
.
12.
Powolny
AA
,
Singh
SV
. 
Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds
.
Cancer Lett
2008
;
269
:
305
14
.
13.
Tsubura
A
,
Lai
YC
,
Kuwata
M
,
Uehara
N
,
Yoshizawa
K
. 
Anticancer effects of garlic and garlic-derived compounds for breast cancer control
.
Anticancer Agents Med Chem
2011
;
11
:
249
53
.
14.
Nagaraj
NS
,
Anilakumar
KR
,
Singh
OV
. 
Diallyl disulfide causes caspase-dependent apoptosis in human cancer cells through a Bax-triggered mitochondrial pathway
.
J Nutr Biochem
2010
;
21
:
405
12
.
15.
Sakamoto
K
,
Lawson
LD
,
Milner
JA
. 
Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells
.
Nutr Cancer
1997
;
29
:
152
6
.
16.
Wu
XJ
,
Kassie
F
,
Mersch-Sundermann
V
. 
The role of reactive oxygen species (ROS) production on diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carcinoma cells
.
Mutat Res
2005
;
579
:
115
24
.
17.
Xiao
D
,
Zeng
Y
,
Hahm
ER
,
Kim
YA
,
Ramalingam
S
,
Singh
SV
. 
Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells
.
Environ Mol Mutagen
2009
;
50
:
201
12
.
18.
Galeone
C
,
Pelucchi
C
,
Levi
F
,
Negri
E
,
Franceschi
S
,
Talamini
R
, et al
Onion and garlic use and human cancer
.
Am J Clin Nutr
2006
;
84
:
1027
32
.
19.
Hsing
AW
,
Chokkalingam
AP
,
Gao
YT
,
Madigan
MP
,
Deng
J
,
Gridley
G
, et al
Allium vegetables and risk of prostate cancer: a population-based study
.
J Natl Cancer Inst
2002
;
94
:
1648
51
.
20.
Kim
JY
,
Kwon
O
. 
Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims
.
Am J Clin Nutr
2009
;
89
:
257
64
.
21.
Dorant
E
,
van den Brandt
PA
,
Goldbohm
RA
. 
A prospective cohort study on Allium vegetable consumption, garlic supplement use, and the risk of lung carcinoma in The Netherlands
.
Cancer Res
1994
;
54
:
6148
53
.
22.
Dorant
E
,
van den Brandt
PA
,
Goldbohm
RA
. 
Allium vegetable consumption, garlic supplement intake, and female breast carcinoma incidence
.
Breast Cancer Res Treat
1995
;
33
:
163
70
.
23.
Dorant
E
,
van den Brandt
PA
,
Goldbohm
RA
. 
A prospective cohort study on the relationship between onion and leek consumption, garlic supplement use and the risk of colorectal carcinoma in The Netherlands
.
Carcinogenesis
1996
;
17
:
477
84
.
24.
Dorant
E
,
van den Brandt
PA
,
Goldbohm
RA
,
Sturmans
F
. 
Consumption of onions and a reduced risk of stomach carcinoma
.
Gastroenterology
1996
;
110
:
12
20
.
25.
Torre
LA
,
Bray
F
,
Siegel
RL
,
Ferlay
J
,
Lortet-Tieulent
J
,
Jemal
A
. 
Global cancer statistics, 2012
.
CA Cancer J Clin
2015
;
65
:
87
108
.
26.
Chen
W
,
Zheng
R
,
Zeng
H
,
Zhang
S
,
He
J
. 
Annual report on status of cancer in China, 2011
.
Chin J Cancer Res
2015
;
27
:
2
12
.
27.
She
J
,
Yang
P
,
Hong
Q
,
Bai
C
. 
Lung cancer in China: challenges and interventions
.
Chest
2013
;
143
:
1117
26
.
28.
Key
TJ
. 
Fruit and vegetables and cancer risk
.
Br J Cancer
2011
;
104
:
6
11
.
29.
Norat
T
,
Aune
D
,
Chan
D
,
Romaguera
D
. 
Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention
.
Cancer Treat Res
2014
;
159
:
35
50
.
30.
Research. WCRFAIfC
. 
Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective
.
Washington, DC
:
AICR
; 
2007
.
31.
Jin
ZY
,
Wu
M
,
Han
RQ
,
Zhang
XF
,
Wang
XS
,
Liu
AM
, et al
Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese population
.
Cancer Prev Res
2013
;
6
:
711
8
.
32.
Le Marchand
L
,
Murphy
SP
,
Hankin
JH
,
Wilkens
LR
,
Kolonel
LN
. 
Intake of flavonoids and lung cancer
.
J Natl Cancer Inst
2000
;
92
:
154
60
.
33.
Lin
Y
,
Cai
L
. 
Environmental and dietary factors and lung cancer risk among Chinese women: a case-control study in southeast China
.
Nutr Cancer
2012
;
64
:
508
14
.
34.
Linseisen
J
,
Rohrmann
S
,
Miller
AB
,
Bueno-de-Mesquita
HB
,
Buchner
FL
,
Vineis
P
, et al
Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC)
.
Int J Cancer
2007
;
121
:
1103
14
.
35.
Satia
JA
,
Littman
A
,
Slatore
CG
,
Galanko
JA
,
White
E
. 
Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study
.
Cancer Epidemiol Biomarkers Prev
2009
;
18
:
1419
28
.
36.
Fleischauer
AT
,
Arab
L
. 
Garlic and cancer: a critical review of the epidemiologic literature
.
J Nutr
2001
;
131
:
1032S
40S
.
37.
Capasso
A
. 
Antioxidant action and therapeutic efficacy of Allium sativum L
.
Molecules
2013
;
18
:
690
700
.
38.
Song
K
,
Milner
JA
. 
The influence of heating on the anticancer properties of garlic
.
J Nutr
2001
;
131
:
1054S
7S
.
39.
Park
JH
,
Park
YK
,
Park
E
. 
Antioxidative and antigenotoxic effects of garlic (Allium sativum L.) prepared by different processing methods
.
Plant Foods Hum Nutr
2009
;
64
:
244
9
.
40.
Shin
JH
,
Ryu
JH
,
Kang
MJ
,
Hwang
CR
,
Han
J
,
Kang
D
. 
Short-term heating reduces the anti-inflammatory effects of fresh raw garlic extracts on the LPS-induced production of NO and pro-inflammatory cytokines by downregulating allicin activity in RAW 264.7 macrophages
.
Food Chem Toxicol
2013
;
58
:
545
51
.
41.
Koch
HP
,
Lawson
LD
. 
Garlic: the science and therapeutic application of Allium sativum L. and related species
:
Baltimore, MD
:
Williams & Wilkins
; 
1996
. p
329
.
42.
Mu
L
,
Liu
L
,
Niu
R
,
Zhao
B
,
Shi
J
,
Li
Y
, et al
Indoor air pollution and risk of lung cancer among Chinese female non-smokers
.
Cancer Causes Control
2013
;
24
:
439
50
.
43.
Wang
XR
,
Chiu
YL
,
Qiu
H
,
Au
JS
,
Yu
IT
. 
The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong
.
Ann Oncol
2009
;
20
:
746
51
.
44.
Zhi
XY
,
Zou
XN
,
Hu
M
,
Jiang
Y
,
Jia
MM
,
Yang
GH
. 
Increased lung cancer mortality rates in the Chinese population from 1973–1975 to 2004–2005: An adverse health effect from exposure to smoking
.
Cancer
2015
;
121
Suppl 17
:
S3107
S12
.
45.
Zhong
L
,
Goldberg
MS
,
Gao
YT
,
Hanley
JA
,
Parent
ME
,
Jin
F
. 
A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China
.
Epidemiology
2001
;
12
:
695
700
.
46.
Cortes-Jofre
M
,
Rueda
JR
,
Corsini-Munoz
G
,
Fonseca-Cortes
C
,
Caraballoso
M
,
Bonfill Cosp
X
. 
Drugs for preventing lung cancer in healthy people
.
Cochrane Database Syst Rev
2012
;
10
:
CD002141
.
47.
Hinds
MW
,
Kolonel
LN
,
Hankin
JH
,
Lee
J
. 
Dietary vitamin A, carotene, vitamin C and risk of lung cancer in Hawaii
.
Am J Epidemiol
1984
;
119
:
227
37
.
48.
Luo
J
,
Shen
L
,
Zheng
D
. 
Association between vitamin C intake and lung cancer: a dose-response meta-analysis
.
Sci Rep
2014
;
4
:
6161
.
49.
Slatore
CG
,
Littman
AJ
,
Au
DH
,
Satia
JA
,
White
E
. 
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer
.
Am J Respir Crit Care Med
2008
;
177
:
524
30
.
50.
Takata
Y
,
Shu
XO
,
Yang
G
,
Li
H
,
Dai
Q
,
Gao
J
, et al
Calcium intake and lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study
.
Cancer Epidemiol Biomarkers Prev
2013
;
22
:
50
7
.
51.
Nicastro
HL
,
Ross
SA
,
Milner
JA
. 
Garlic and onions: their cancer prevention properties
.
Cancer Prev Res
2015
;
8
:
181
9
.
52.
U.S. Department of Agriculture ARS
. 
USDA National Nutrient Database for Standard Reference, Release 27
.
Nutrient Data Laboratory Home Page
; 
2014
.
53.
Schafer
G
,
Kaschula
CH
. 
The immunomodulation and anti-inflammatory effects of garlic organosulfur compounds in cancer chemoprevention
.
Anticancer Agents Med Chem
2014
;
14
:
233
40
.
54.
Aboyade-Cole
A
,
Darling-Reed
S
,
Oriaku
E
,
McCaskill
M
,
Thomas
R
. 
Diallyl sulfide inhibits PhIP-induced cell death via the inhibition of DNA strand breaks in normal human breast epithelial cells
.
Oncol Rep
2008
;
20
:
319
23
.
55.
Lu
X
,
Ross
CF
,
Powers
JR
,
Aston
DE
,
Rasco
BA
. 
Determination of total phenolic content and antioxidant activity of garlic (Allium sativum) and elephant garlic (Allium ampeloprasum) by attenuated total reflectance-Fourier transformed infrared spectroscopy
.
J Agric Food Chem
2011
;
59
:
5215
21
.
56.
Wilson
C
,
Aboyade-Cole
A
,
Newell
O
,
Darling-Reed
S
,
Oriaku
E
,
Thomas
R
. 
Diallyl sulfide inhibits PhIP-induced DNA strand breaks in normal human breast epithelial cells
.
Oncol Rep
2007
;
17
:
807
11
.
57.
Wang
Y
,
Li
F
,
Wang
Z
,
Qiu
T
,
Shen
Y
,
Wang
M
. 
Fruit and vegetable consumption and risk of lung cancer: a dose-response meta-analysis of prospective cohort studies
.
Lung Cancer
2015
;
88
:
124
30
.
58.
Boivin
D
,
Lamy
S
,
Lord-Dufour
S
,
Jackson
J
,
Beaulieu
E
,
Côté
M
, et al
Antiproliferative and antioxidant activities of common vegetables: a comparative study
.
Food Chem
2009
;
112
:
374
80
.
59.
Hui
C
,
Jun
W
,
Ya
LN
,
Ming
X
. 
Effect of Allium sativum (garlic) diallyl disulfide (DADS) on human non-small cell lung carcinoma H1299 cells
.
Trop Biomed
2008
;
25
:
37
45
.
60.
Li
W
,
Tian
H
,
Li
L
,
Li
S
,
Yue
W
,
Chen
Z
, et al
Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo
.
Acta Biochim Biophys Sin
2012
;
44
:
577
83
.
61.
Herman-Antosiewicz
A
,
Singh
SV
. 
Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review
.
Mutat Res
2004
;
555
:
121
31
.
62.
Hong
JY
,
Wang
ZY
,
Smith
TJ
,
Zhou
S
,
Shi
S
,
Pan
J
, et al
Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung
.
Carcinogenesis
1992
;
13
:
901
4
.
63.
Singh
SV
,
Pan
SS
,
Srivastava
SK
,
Xia
H
,
Hu
X
,
Zaren
HA
, et al
Differential induction of NAD(P)H:quinone oxidoreductase by anti-carcinogenic organosulfides from garlic
.
Biochem Biophys Res Commun
1998
;
244
:
917
20
.
64.
Howard
EW
,
Ling
MT
,
Chua
CW
,
Cheung
HW
,
Wang
X
,
Wong
YC
. 
Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer
.
Clin Cancer Res
2007
;
13
:
1847
56
.
65.
Tanaka
S
,
Haruma
K
,
Yoshihara
M
,
Kajiyama
G
,
Kira
K
,
Amagase
H
, et al
Aged garlic extract has potential suppressive effect on colorectal adenomas in humans
.
J Nutr
2006
;
136
:
821S
6S
.
66.
Lam
S
,
MacAulay
C
,
Le Riche
JC
,
Dyachkova
Y
,
Coldman
A
,
Guillaud
M
, et al
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia
.
J Natl Cancer Inst
2002
;
94
:
1001
9
.
67.
Giovino
GA
,
Mirza
SA
,
Samet
JM
,
Gupta
PC
,
Jarvis
MJ
,
Bhala
N
, et al
Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
.
Lancet
2012
;
380
:
668
79
.
68.
World Health Organization Representative Office C
. 
Tobbaco in China
. 
2015
[cited 2015 Jun 22]. Available from
: http://www.wpro.who.int/china/mediacentre/factsheets/tobacco/en/.
69.
Services USDoHaH
. 
The Health Benefits of Smoking Cessation
.
Atlanta, GA
:
U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
; 
1990
.
Report No.: DHHS Publication No. (CDC) 90-8416
.
70.
U.S. Department of Health and Human Services
. 
The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General
.
Atlanta, GA
:
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
; 
2006
.
71.
U.S. Department of Health and Human Services
. 
The Health Consequences of Smoking-50 years of Progress: A Report of the Surgeon General
.
Atlanta, GA
:
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
; 
2014
.